EUVIMEDEUVIMED entdecken
Crossref

SEM1 promotes tumor progression of glioblastoma via activating the akt signaling pathway

Chuntao Li, Bo Chen, Junxia Zhang, Jingxuan Yang, Muzi Guo, Yu Ren, Zhijun Zhou, Kar-Ming Fung, Min Li, Liyang Zhang, Zhixiong Liu

Cancer Letters · 2023

DOI: 10.1016/j.canlet.2023.216368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2023. Verfasst von Chuntao Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan, 410008, China; Department of Medicine, And …. Hauptthemen laut MEDLINE: Glioblastoma, Glioma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: SEM1, a 26 S proteasome complex subunit, is an essential regulator of tumor growth. However, the underlying mechanism of SEM1 mediated glioma progression remains to be elucidated. METHODS: Data from bulk-tumor, single-cell, and spatial sequencing were analyzed to reveal correlations between SEM1 and clinical traits, cell types, and functional enrichment in gliomas. Immunohistochemistry was used to assess SEM1 expression. MTT, flow cytometry, apoptosis signature, epithelial-mesenchymal transition signature, Transwell, and organoid assays were used to study SEM1's effect on the malignant behavior of glioma (U251 and LN229) cells. Weighted gene co-expression network analysis (WGCNA) was conducted to construct an SEM1-mediated malignant regulatory network. Accordingly, survival analysis, therapeutic response, drug prediction, and molecular docking analyses were performed. RESULTS: High SEM1 expression was observed in gliomas and correlated with worse clinical features and prognosis. Moreover, SEM1 is mainly localized in malignant cells (glioma cells). SEM1 knockout inhibited the proliferation, invasion, and migration of glioma cells and promoted their apoptosis. We also constructed an SEM1 malignant regulatory network that was bridged by the PI3K-Akt pathway. The network had a high prognostic value. Finally, drugs potentially targeting SEM1 were screened and docked to SEM1. CONCLUSIONS: SEM1 is critically involved in the proliferation, apoptosis, invasion, and migration of glioma cells. The SEM1 malignant regulatory network shows high significance for the prognosis and treatment of gliomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaGliomaHumansProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesMolecular Docking SimulationCell ProliferationCell Line, TumorSignal TransductionApoptosisCell Movement

Stichwörter der Autor:innen

ApoptosisDrugGliomaInvasionMigrationPrognosisProliferationSEM1

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Neurosurgery, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan, 410008, China; Department of Medicine, And Department of Surgery, The University of Oklahoma Health Sciences Cent…
  • Department of Neurosurgery, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan, 410008, China; Hypothalamic-pituitary Research Center, Xiangya Hospital, Central South University, Changsha, Huna…
  • Department of Medicine, And Department of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical Universit…
  • Department of Medicine, And Department of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
  • Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
  • Department of Medicine, And Department of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA. Electronic address: min-li@ouhsc.edu.

Zitieren

APA

Li, C., Chen, B., Zhang, J., Yang, J., Guo, M., Ren, Y., Zhou, Z., Fung, K. M., Li, M., Zhang, L., & Liu, Z. (2023). SEM1 promotes tumor progression of glioblastoma via activating the akt signaling pathway. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216368

Vancouver

Li C, Chen B, Zhang J, Yang J, Guo M, Ren Y, et al. SEM1 promotes tumor progression of glioblastoma via activating the akt signaling pathway. Cancer Letters. 2023. doi:10.1016/j.canlet.2023.216368

BibTeX
@article{Li2023,
  author = {Li, Chuntao and Chen, Bo and Zhang, Junxia and Yang, Jingxuan and Guo, Muzi and Ren, Yu and Zhou, Zhijun and Fung, Kar-Ming and Li, Min and Zhang, Liyang and Liu, Zhixiong},
  title = {SEM1 promotes tumor progression of glioblastoma via activating the akt signaling pathway},
  journal = {Cancer Letters},
  year = {2023},
  doi = {10.1016/j.canlet.2023.216368}
}
Kostenlos starten →